FINAL Overview - Evidence - Base - Briefing
FINAL Overview - Evidence - Base - Briefing
FINAL Overview - Evidence - Base - Briefing
Psychoanalytic psychotherapy has a strong and expanding evidence base. There now exists a large
number of outcome studies which have alternately examined the efficacy of short-term and long-
term psychoanalytic psychotherapy and the efficacy of psychoanalytic psychotherapy for specific
conditions. Of particular note is the consistent finding from this research of significantly increased
long-term follow up effect sizes: patients continue to make considerable gains long after treatment
has ended. There is also evidence that non-psychoanalytic forms of therapy may be effective because
of the inclusion of psychoanalytic techniques and process. Psychoanalytic and psychodynamic
psychotherapy are essentially interchangeable terms and for the purposes of brevity this paper uses
the term psychoanalytic.
Summary
There are now a significant number of well-designed studies which demonstrate the
efficacy of psychoanalytic psychotherapy. The research is objectively strong.
Psychoanalytic psychotherapy yields impressive effect sizes, with effect sizes
typically increasing at long-term follow up, suggesting that patients who receive
psychoanalytic psychotherapy experience continuing psychological benefits long
after therapy has ended.
Longer-term psychoanalytic psychotherapy (one year’s treatment or more) is more
effective than shorter forms of therapy for the treatment of complex mental
disorders.
Psychoanalytic psychotherapy has particularly promising findings in relation to
helping people with personality disorder. Mentalization-based therapy (a form of
psychoanalytic psychotherapy) has been shown to yield the most positive results for
personality pathology.
A growing body of evidence suggests that psychoanalytic psychotherapy is effective
for many common mental disorders, including depressive disorders, anxiety
disorders, eating disorders, post-traumatic stress disorder and substance-related
disorder.
There is also a growing body of evidence which suggests that non-psychoanalytic
therapies benefit from the inclusion of psychoanalytic processes and techniques.
Given the growing evidence base, it is time commissioners and health policy makers
turned their attention to psychoanalytic psychotherapy. It could help a great many
people with unmet mental health needs in the country.
Introduction
Psychoanalytic psychotherapy has endured a storm of criticism in recent years. Detractors
have pointed out that it lacks scientific credibility and health care policy makers now often
2
assume that its evidence base is weak and patchy. Concurrent with this prevailing opinion
has been the rise of other forms of ‘talking treatment’, some of which, in particular
cognitive behavioural therapy (CBT), have undergone thousands of studies that show their
effectiveness. Faced with the choice of commissioning a therapy such as CBT, which
appears to promise a fast cure and has a good evidence base, or of commissioning a therapy
such as psychoanalytic psychotherapy, which offers a longer course of treatment and
appears to have a weak evidence base, is it any wonder which choice commissioners have
all too often made?
The psychoanalytic community also needs to accept some responsibility for this state of
affairs. Until relatively recently, the community at large was slow, and even at times averse,
to conducting research. Research methods such as manualisation of treatments or
randomisation of patients seemed removed from clinical reality, and there was sometimes a
sense of anxiety of having to question beliefs about theory and technique collectively built
up from individual clinical experience and clinical lore. Moreover, much of the research that
was conducted historically lacked methodological rigour.
Nevertheless, the reader should note the deliberate reference to history. This is because,
gradually, and increasingly at a faster pace, the psychoanalytic community has come to
appreciate the value of research. As this paper will detail, there are now a significant
number of respectable, well-designed studies which demonstrate the efficacy of
psychoanalytic psychotherapy. The culture towards research is changing.
This paper presents the lay reader with some of the key findings from the research. In this
continuing climate of austerity and vastly cut back mental health services, the reader may
be particularly interested to note that the research suggests psychoanalytic therapy has a
significant positive long-term effect on patients. Although, as with any form of treatment,
there is still scope for further research, objectively the evidence is strong. The time has now
come when commissioners and health care policy makers should turn their attention to
psychoanalytic psychotherapy.
subjects, and verbally intervenes in a range of ways – from offering empathy to more
exploratory or challenging interventions, such as interpretations.
Interpretations: the therapist offers these in order to help the patient gain insight into
repetitive conflicts prolonging their problems (Gabbard, 2004) and to aid the patient in
understanding their unconscious themes.
Use of the countertransference: the therapist also carefully notes their own feelings, or
‘countertransference’ towards the patient and the patient’s discourse. These can offer
insight into how the patient relates to people.
After analysing many hundreds of hours of transcripts and recordings of therapy sessions,
Blagys and Hilsenroth (2000) identified seven core processes and techniques which
distinguish manualised psychoanalytic psychotherapy from other therapies:
1) Explaining emotions: patients are encouraged to explore their emotions in depth.
The therapist helps the patient to identify how they feel, putting contradictory and
troubling feelings into words. It is believed that emotional insight, in contrast to
intellectual insight, can lead to profound change.
2) Exploring efforts to avoid distressing thoughts and feelings: people do things to avoid
thoughts and feelings which trouble them in a variety of ways – from the subtle –
focusing on facts rather than how they feel about something – to the more obvious –
such as going quiet in a session. The therapist will encourage the patient to explore
what is distressing them.
3) Identifying reoccurring patterns: the therapist will try to identify and explore
recurring patterns in patients’ thoughts, feelings, relationships and life. Patients may
be extremely aware or they may be distressingly unaware of such patterns.
6) Considering the relationship between the patient and therapist: the therapist will
examine this relationship (sometimes referred to as ‘transference’) because patients
tend to interact with their therapist in the same way they will interact with other
people.
desires, dreams and fantasies. These thoughts are a potential treasure chest of
information into the patient.
Above all, the aim of psychoanalytic psychotherapy is to go beyond remission of symptoms
and to instil psychological strengths in a patient, giving patients the ability to better face
Research Terms
Control Group: group in an experiment that receives no treatment or a different treatment to
the experimental group. Allows researchers to compare to the experimental group.
Effect size: a way of quantifying how effective an intervention is, measuring the size of the
difference between an experimental group and a control group. An effect size of 0.8 represents
a large effect size, 0.5 a medium effect size and 0.2 a small effect size.
Efficacy: how far an intervention is able to cause its intended effect during clinical trials.
Long-term follow up: where patients who underwent an intervention are revisited after an
interval of time to measure the treatment effect size after this time interval.
Meta-analysis: statistically comparing results from independent studies with related hypotheses,
to reach conclusions about the efficacy of 1 or more treatments.
Randomized controlled trial: a type of scientific experiment whereby patients are randomly
allocated to receive one or other of the different treatments being studied, after which any
differences detected between patients should be because of the treatments under comparison,
and not due to any other factor.
difficulties and challenges and the capacity to live a fuller and richer life in the present.
The evidence:
1) For psychoanalytic psychotherapy in general
The past two decades have seen a rise in the number of high-quality randomised controlled
trials (RCTs) of psychoanalytic psychotherapy. Shedler (2010) highlights various meta-
analyses, which aggregate results from these RCTS and demonstrate that psychoanalytic
psychotherapies yield impressive effect sizes. Among these, there is, for example, a meta-
analysis published by the Cochrane Library, which examined 23 RCTs of a total of 1,431
patients (Abbass, Hancock, Henderson et al, 2006). The RCTs compared patients with a
range of common mental disorders who received short-term psychoanalytic psychotherapy
with controls who received minimal treatment and non-treatment interventions, yielding an
overall effect size of 0.97 for general symptom improvement. This effect size increased to
1.51 when the patients were assessed 9 months after treatment. The meta-analysis also
reported an effect size of 0.81 for change in somatic symptoms, increasing to 2.21 at long-
term follow up; an effect size of 1.08 for change in anxiety ratings, increasing to 1.35 at
follow up; and an effect size of 0.59 for change in depressive symptoms, which increased to
0.98 at follow-up. This trend to larger effect sizes at follow up suggests that patients who
received psychoanalytic psychotherapy experience continuing psychological benefits long
after therapy has ended.
5
By contrast, the benefits of other therapies tend to decay over time (de Maat, Dekker, Schoevers
et al, 2006; Hollon et al, 2005; Westen, Novotny, and Thompson-Brenner, 2004; excepting
manualized treatments for specific anxiety conditions – see Westen et al, 2004).
(Leichsenring and Rabung, 2008; de Matt et al, 2009) examined the efficacy of longer-term
psychoanalytic psychotherapy (one year’s treatment or more). Leichsenring and Rabung
compared longer-term psychoanalytic therapy with shorter forms of therapy for the
treatment of complex mental disorders (defined as multiple or chronic mental disorders, or
personality disorders) and found it to be much more effective than shorter forms of
therapy. An overall effect size of 1.8 was found, with a pre-treatment to post-treatment
overall effect size of 1.03, which increased to 1.25 at long-term follow up. De Maat et al
examined the effectiveness of long-term psychoanalytic psychotherapy for patients with a
range of DSM (Diagnostic and Statistical Manual of Mental Disorders, American Psychiatric
Association) diagnoses. For patients with mixed/moderate pathology, the pre-treatment to
post-treatment effect size was 0.78 for general symptom improvement, increasing to 0.94 at
long-term follow up, at an average of 3.2 years after treatment. For patients with severe
personality pathology, the pre-treatment to post-treatment effect was 0.94, increasing to
1.02 at long-term follow up, at an average of 5.2 years after follow up.
Shedler (2010) highlights a number of studies which suggest that psychoanalytic processes
and techniques are used by non-psychoanalytic therapists and lead to successful outcome in
non-analytic therapies (such as Diener, Hilsenroth and Weinberger, 2007; Hoglend et al,
2008; Vocisano et al, 2004). Among these, ones associated with the Psychotherapy Process
Q-Sort (PQS) might be of most interest (Jones, 2000). The PQS includes 100 variables which
assess the therapy process based on matters such as the behaviour and actions of the
therapist. A study by Ablon and Jones (1998) for example, asked experts in CBT and
psychoanalytic therapy to use the PQS to describe ideally conducted treatments. Following
feedback from these experts, prototypes of ideally constructed CBT and psychoanalytic
psychotherapy were made. The CBT prototype focused on highly structured treatment,
with the therapist introducing topics and discussing patient treatment goals. The
psychoanalytic prototype focused on unstructured, open-ended dialogue, with the therapist
identifying recurring themes in the patient’s experience and drawing attention to feelings
regarded by the patient as unacceptable. Ablon and Jones examined three archival
treatment records (one for cognitive therapy, two for brief psychodynamic therapy),
focusing on therapist adherence to each therapy prototype without regard to the treatment
model the therapists thought they were applying. Therapist adherence to the
psychoanalytic prototype predicted successful outcome in both psychoanalytic and
cognitive therapy, whereas therapist adherence to the CBT prototype beared little or no
relation to outcome in either type of therapy. These findings echo those of Jones and Pulos
(1993) who found that psychoanalytic interventions predicted successful outcome for both
psychoanalytic and cognitive therapy. Other studies have reported positive relations
between CBT technique and outcome (such as Strunk, DeRubeis, Chiu et al, 2007) but
findings suggest that the more effective therapists utilise psychoanalytic process and
techniques.
Conclusions
One can now state with confidence that the evidence base for psychoanalytic
psychotherapy is strong and credible and that psychoanalytic psychotherapy is efficacious in
the treatment of a wide range of mental health conditions and disorders. A historical
antipathy to research in the psychoanalytic community is increasingly giving way to active
and willing involvement in research. Moreover, after a spate of poor trials (with for
example, too small patient samples), studies are now becoming much tighter and more
methodologically rigorous. In this way, research in psychoanalytic psychotherapy is
beginning to catch up with the large number of methodologically sound RCTs conducted on
other forms of therapy such as CBT.
There is also a real incentive for commissioners and health policy makers to turn to
psychoanalytic psychotherapy. As the public policy landscape points out (for example, the
British Psychoanalytic Council and UK Council for Psychotherapy, 2015; Mind, 2013, 2014)
many people who would benefit from psychoanalytic psychotherapy are currently unable to
access appropriate treatments on the NHS. It is therefore of acute concern that an
increasing number of NHS services providing psychoanalytic forms of treatment are being
8
References
APA. (2013) Diagnostic and statistical manual of mental disorders 5th ed. Washington, DC.
Westen, D., Gabbard, G., Blavgo, P (2006) Back to the future: Personality structure as a
context for psychopathology. From R.F. Krueger & J.L. Tackett, Personality and
psychopathology (pp.335-384). New York, NY: Guilford Press.
Westen, D., Novotny, CM., Thompson-Brenner, H (2004) The empirical status of empirically
supported psychotherapies: Assumptions, findings and reporting in controlled clinical trials.
Psychological Bulletin, 130: 631-663.
Winston, A., Laikin, M., Pollack, J., Samstag, LW., McCullough, L., & Muran, JC (1994). Short
term psychotherapy of personality disorders. American Journal of Psychiatry, 151: 190-194.
Yakeley, J. (2014). Psychodynamic psychotherapy: developing the evidence base. Advances
in psychiatric treatment, 20: 269 – 279.